• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    66 Biggest Movers From Friday

    5/23/22 3:57:58 AM ET
    $AEMD
    $ALLR
    $ATHX
    $BJ
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEMD alert in real time by email

    Gainers

    • GeoVax Labs, Inc. (NASDAQ:GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
    • Leju Holdings Limited (NYSE:LEJU) shares jumped 53.4% to close at $4.85 on Friday.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) jumped 43.4% to close at $12.40 on Friday. SIGA Technologies announced the FDA approved the intravenous formulation of TPOXX for the treatment of smallpox.
    • NanoViricides, Inc. (NYSE:NNVC) gained 40.5% to close at $2.60.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) surged 40% to close at $3.81.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) shares gained 36.6% to close at $3.10 after the company announced that it has received FDA approval of its supplemental New Drug Application for ANNOVERA.
    • EBET, Inc. (NASDAQ:EBET) gained 33.7% to close at $3.85.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 30.1% to settle at $2.12 after the company highlighted its IMX-110 showed improved survival over J&J's Janssen's FDA-approved drug Trabectedin in a connective tissue cancer Soft Tissue Sarcoma mice study.
    • The Beachbody Company, Inc. (NYSE:BODY) rose 26.7% to close at $1.61. Beachbody’s Co-Founder and Vice Chairman Jonathan Congdon reported the purchase of 200,000 shares at an average price of $1.22 per share in Form 4 Filing on Friday.
    • Journey Medical Corporation (NASDAQ:DERM) gained 26.1% to close at $4.50.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) jumped 25% to settle at $2.05.
    • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) gained 23.8% to close at $0.90. The company recently posted a quarterly loss of $0.03 per share.
    • Portage Biotech Inc. (NASDAQ:PRTG) gained 23% to close at $8.14.
    • MDxHealth SA (NASDAQ:MDXH) rose 22.8% to close at $9.33.
    • Getnet Adquirência e Serviços para Meios de Pagamento S.A. (NYSE:GET) jumped 21.8% to settle at $1.79 after gaining around 5% on Thursday.
    • iBio, Inc. (NYSE:IBIO) gained 20.2% to close at $0.28. iBio recently posted a Q3 loss of $0.06 per share.
    • Exicure, Inc. (NASDAQ:XCUR) shares climbed 19.8% to close at $0.1450. Exicure said in Form4 filing a director bought 1.47 million shares at an average price of 19 cents/share.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) gained 18.3% to close at $6.65. Tenaya Therapeutics will present preclinical data on TN-301 HDAC6 inhibitor at European Society of Cardiology Heart Failure 2022 Conference.
    • Foghorn Therapeutics Inc. (NASDAQ:FHTX) jumped 18.1% to close at $13.52. Foghorn Therapeutics announced the FDA placed the Phase 1 dose escalation study of FHD-286 in relapsed and/or refractory acute myelogenous leukemia and myelodysplastic syndrome on a partial clinical hold.
    • Applied Blockchain, Inc. (NASDAQ:APLD) jumped 18.1% to settle at $3.65 after company CEO Wes Cummins reported the purchase of 391,474 shares at an average price of $2.38 per share in a Form 4 filing on Thursday.
    • Permian Basin Royalty Trust (NYSE:PBT) climbed 17.1% to close at $16.40.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) gained 17% to settle at $1.31.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) jumped 15.8% to close at $0.9208. The FDA recently reviewed NeuroOne Medical Technologies Corporation's appeal for 510(k) clearance for its Evo sEEG Electrode for less than 30-day use.
    • Context Therapeutics Inc. (NASDAQ:CNTX) rose 14.9% to close at $1.77. The company recently posted a narrower quarterly loss.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) surged 14.9% to close at $2.54.
    • ClearPoint Neuro, Inc. (NASDAQ:CLPT) gained 13.6% to close at $9.78. ClearPoint Neuro will present investigational research and exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC.
    • Versus Systems Inc. (NASDAQ:VS) jumped 13.2% to settle at $0.5602.
    • Deckers Outdoor Corporation (NYSE:DECK) climbed 12.6% to close at $255.28 after the company reported better-than-expected Q4 EPS and sales results and issued guidance.
    • Palo Alto Networks, Inc. (NASDAQ:PANW) shares climbed 9.7% to close at $478.68 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 financial guidance.
    • Covetrus, Inc. (NASDAQ:CVET) rose 9.4% to close at $19.71 after VFC Holdings in an amended 13D filing said on May 19th, Clayton, Dubilier & Rice and TPG submitted a non-binding proposal to acquire Covetrus for $21 per share.
    • Höegh LNG Partners LP (NYSE:HMLP) gained 8.9% to settle at $6.73.
    • Datasea Inc. (NASDAQ:DTSS) gained 7.5% to close at $1.57. Datasea recently posted a Q3 loss of $0.05 per share.
    • Kronos Bio, Inc. (NASDAQ:KRON) gained 7.3% to close at $3.81. Kronos Bio recently posted a Q1 loss of $0.65 per share.
    • Chimerix, Inc. (NASDAQ:CMRX) gained 6.8% to close at $2.35. Chimerix recently announced the sale of its smallpox treatment to Emergent BioSolutions.
    • Eve Holding, Inc. (NYSE:EVEX) shares gained 6.2% to close at $8.87.

     

     


    Losers

    • Athersys, Inc. (NASDAQ:ATHX) shares dipped 65.5% to settle at $0.2606 on Friday after the company announced that its partner, Healios, reported topline results for its Japan ischemic stroke study, TREASURE. The primary endpoint did not reach statistical significance.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) shares tumbled 63.2% to close at $0.4051 on Friday after reporting pricing of approximately $26.6 million public offering.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) fell 33.3% to close at $1.02. Creative Medical Technology, last month, announced a $17 million private placement priced at-the-market under Nasdaq rules.
    • Bright Green Corporation (NASDAQ:BGXX) shares declined 28.3% to close at $11.25 after tumbling 67% on Thursday. Bright Green, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 27.9% to close at $2.20.
    • Molecular Data Inc. (NASDAQ:MKD) dipped 24.9% to close at $0.0756. Molecular Data announced a 15-for-1 reverse stock split.
    • Ross Stores, Inc. (NASDAQ:ROST) fell 22.5% to close at $71.87 after the company reported worse-than-expected Q1 EPS and sales results. The company also issued Q2 EPS guidance below analyst estimates.
    • NeuroMetrix, Inc. (NASDAQ:NURO) fell 21.6% to close at $4.31. NeuroMetrix shares jumped 76% on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.
    • Scienjoy Holding Corporation (NASDAQ:SJ) dropped 20.2% to settle at $2.37.
    • Endo International plc (NASDAQ:ENDP) fell 19.5% to close at $0.4650. Endo International recently initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported.
    • Biophytis S.A. (NASDAQ:BPTS) fell 19.4% to close at $1.16.
    • Eqonex Limited (NASDAQ:EQOS) dropped 18.7% to close at $1.00. EQONEX recently named Daniel Ling as CFO.
    • PolarityTE, Inc. (NASDAQ:PTE) dipped 17.8% to settle at $2.35.
    • Oblong Inc. (NASDAQ:OBLG) declined 17.1% to close at $0.29. The company recently posted downbeat quarterly sales.
    • Magenta Therapeutics, Inc. (NASDAQ:MGTA) fell 16.4% to close at $1.22. Magenta Therapeutics recently posted Q1 loss of $0.39 per share.
    • Flora Growth Corp. (NASDAQ:FLGC) dropped 16% to settle at $1.05.
    • Forge Global Holdings, Inc. (NYSE:FRGE) dipped 15.1% to close at $17.71.
    • Burlington Stores, Inc. (NYSE:BURL) dropped 15% to close at $150.71 in sympathy with Ross Stores after the company reported worse-than-expected Q1 financial results and issued Q2 EPS guidance below analyst estimates.
    • Decisionpoint Systems, Inc. (NYSE:DPSI) fell 14.8% to settle at $5.95.
    • Deere & Company (NYSE:DE) dropped 14.1% to close at $313.31 after the company reported Q2 financial results.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) declined 13.9% to settle at $3.28. Snow Lake Lithium reported results from its first drill tests from the Grass River Pegmatite dyke. The company also said its exploration permits have been extended by the Province of Manitoba for 3 years.
    • Sky Harbour Group Corporation (NYSE:SKYH) fell 13.5% to close at $8.52.
    • Citi Trends, Inc. (NASDAQ:CTRN) fell 13.2% to close at $25.43. Craig-Hallum downgraded Citi Trends from Buy to Hold.
    • Kohl's Corporation (NYSE:KSS) fell 13% to close at $39.20 after several analysts lowered their price targets on the stock.
    • Cyngn Inc. (NASDAQ:CYN) fell 10.6% to close at $2.03.
    • BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) shares dropped 8.9% to close at $52.29. BJ's Wholesale Club recently reported better-than-expected Q1 EPS and sales results.
    • Borr Drilling Limited (NYSE:BORR) fell 8.8% to close at $5.06.
    • Rent the Runway, Inc. (NASDAQ:RENT) fell 8.1% to close at $3.86.
    • Indaptus Therapeutics, Inc. (NASDAQ:INDP) fell 7.4% to close at $2.75. The U.S. Food and Drug Administration (FDA) recently announced clearance to Indaptus Therapeutics’ Investigational New Drug (IND) application for a Phase 1 clinical trial of its drug candidate Decoy20 in patients with advanced solid tumors where currently approved therapies have failed.
    • GDS Holdings Limited (NYSE:GDS) dropped 6.9% to close at $28.95.
    • Nordstrom, Inc. (NYSE:JWN) declined 6.4% to close at $21.18.
    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $ALLR
    $ATHX
    $BJ

    CompanyDatePrice TargetRatingAnalyst
    Deckers Outdoor Corporation
    $DECK
    1/30/2026$105.00 → $120.00Market Perform
    Telsey Advisory Group
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/28/2026$90.00Buy → Hold
    Jefferies
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/23/2026$100.00Buy → Hold
    Melius
    Kohl's Corporation
    $KSS
    1/14/2026$22.00Hold
    Jefferies
    Deckers Outdoor Corporation
    $DECK
    1/14/2026$102.00Hold
    Jefferies
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/8/2026Hold
    Deutsche Bank
    Ross Stores Inc.
    $ROST
    1/8/2026Buy
    Deutsche Bank
    Burlington Stores Inc.
    $BURL
    1/8/2026$318.00Hold
    Deutsche Bank
    More analyst ratings

    $AEMD
    $ALLR
    $ATHX
    $BJ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Gottschalk Adrian

    4 - Foghorn Therapeutics Inc. (0001822462) (Issuer)

    2/6/26 4:01:11 PM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, Finance Higa Tomohiro was granted 29,250 shares, increasing direct ownership by 31% to 123,221 units (SEC Form 4)

    4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)

    2/5/26 6:03:28 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Medical Officer Tingley Whittemore was granted 48,750 shares, increasing direct ownership by 28% to 223,778 units (SEC Form 4)

    4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)

    2/5/26 6:02:44 PM ET
    $TNYA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Deckers Outdoor with a new price target

    Telsey Advisory Group reiterated coverage of Deckers Outdoor with a rating of Market Perform and set a new price target of $120.00 from $105.00 previously

    1/30/26 6:49:41 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    BJ's Wholesale downgraded by Jefferies with a new price target

    Jefferies downgraded BJ's Wholesale from Buy to Hold and set a new price target of $90.00

    1/28/26 7:13:07 AM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    BJ's Wholesale downgraded by Melius with a new price target

    Melius downgraded BJ's Wholesale from Buy to Hold and set a new price target of $100.00

    1/23/26 8:12:49 AM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO and Chairman Rachman Ilya M bought $4,976 worth of shares (746 units at $6.67), increasing direct ownership by 0.07% to 1,141,683 units (SEC Form 4)

    4 - Immix Biopharma, Inc. (0001873835) (Issuer)

    12/10/25 6:49:30 PM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CFO Morris Gabriel S exercised 156,000 in-the-money shares at a strike of $0.80 and bought $5,067 worth of shares (770 units at $6.58), increasing direct ownership by 0.26% to 291,429 units (SEC Form 4)

    4 - Immix Biopharma, Inc. (0001873835) (Issuer)

    12/10/25 6:47:20 PM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ALLR
    $ATHX
    $BJ
    SEC Filings

    View All

    SEC Form 6-K filed by GDS Holdings Limited

    6-K - GDS Holdings Ltd (0001526125) (Filer)

    2/6/26 8:43:35 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by GDS Holdings Limited

    6-K - GDS Holdings Ltd (0001526125) (Filer)

    2/6/26 8:03:49 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by GDS Holdings Limited

    6-K - GDS Holdings Ltd (0001526125) (Filer)

    2/6/26 8:01:26 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BetterInvesting™ Magazine Update on ServiceNow Inc. (NYSE: NOW) and Deckers Outdoors Corp. (NYSE: DECK)

    TROY, Mich., Feb. 6, 2026 /PRNewswire/ -- ServiceNow Inc.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers ServiceNow (NYSE:NOW) as worthy of further study and has named the company its "Stock to Study" for the April 2026 issue for investors' informational and educational use. The fundamental data is eye-opening; investors can view ServiceNow's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at:  https://ssg.betterinvesting.org/trial/ssgplus/?ticke

    2/6/26 7:29:00 AM ET
    $DECK
    $NOW
    Shoe Manufacturing
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Palo Alto Networks NextWave Program Accelerates Partner Profitability and AI-Driven Security Outcomes

    Evolution shifts focus to "Platformization," rewarding technical expertise and service-led growth SANTA CLARA, Calif., Feb. 5, 2026 /PRNewswire/ -- Palo Alto Networks (NASDAQ:PANW), the global cybersecurity leader, today announced the next generation of its NextWave Partner Program, fundamentally redefining partner profitability for the AI era. As the industry moves toward AI-driven security, NextWave moves beyond transactional volume to reward partners who deliver platform-centric security outcomes. The evolved program enables the entire partner ecosystem to move away from the 'point-product' trap. By focusing on platformization, Palo Alto Networks enables partners to integrate their custo

    2/5/26 8:15:00 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    Cyngn Advances Site-Wide Autonomy With DriveMod Tugger Operations Across Connected Facilities

    MOUNTAIN VIEW, Calif., Feb. 5, 2026 /PRNewswire/ -- Cyngn Inc. (NASDAQ:CYN) today highlighted continued expansion of DriveMod Tugger deployments across large, connected industrial facilities, reflecting growing customer demand for site-wide autonomy that supports end-to-end material movement. DriveMod is increasingly being used in workflows that span multiple buildings and outdoor transit corridors, helping organizations reduce bottlenecks, improve throughput consistency, and redeploy labor toward higher-value operations. As warehouses and manufacturing campuses grow larger—of

    2/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Partners with Chandler Automation, Expands into Agriculture

    MOUNTAIN VIEW, Calif., Dec. 23, 2025 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced that Chandler Automation has joined its dealer network and will begin offering Cyngn's autonomous DriveMod Tugger to food processors and packers in the agriculture sector. Chandler Automation is a full-service partner in factory automation, specializing in optical sorting, inspection, robotic palletizing, and custom processing machinery. Known for delivering tailored, high-performance systems, Chandler empowers food processors to reduce labor costs, boost efficiency, and stay competitive wi

    12/23/25 7:00:00 AM ET
    $CYN
    EDP Services
    Technology

    Kohl's Renews Hunger Task Force Partnership with $750,000 Donation to Help Fight Food Insecurity in Milwaukee

    Funding supports nutritious free meals for children, families, and seniors across the Milwaukee area Kohl's (NYSE:KSS) today announced the renewal of its partnership with Hunger Task Force and a $750,000 commitment over the next year to ensure more Milwaukee-area children, families, and seniors have access to healthy, free food. Coming at a time of growing need, the donation extends Kohl's hometown partnership with Hunger Task Force and will help sustain its network of more than 60 food pantries, soup kitchens, and homeless shelters. Funding will also help fill the gap in food access that many youth face during the summer through next year's Summer Meals Program. "Together with Hunger Tas

    12/10/25 8:00:00 AM ET
    $KSS
    Department/Specialty Retail Stores
    Consumer Discretionary

    Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

    CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ms. Ishak will lead Tonix's legal, corporate governance, and compliance functions. "Irina is a highly accomplished corporate and commercial attorney whose experience spans public and private life sciences companies, as well as advising life sciences investors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "Her deep background in complex transactions, public company matters, and governa

    12/9/25 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Financials

    Live finance-specific insights

    View All

    Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

    SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2025, at 4:15 p.m. ET on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session. Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10206585/1034

    2/4/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Borr Drilling Limited - Invitation to Webcast and Conference Call for Q4 2025 Results

    HAMILTON, Bermuda, Jan. 30, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE and Euronext Growth Oslo: BORR) (the "Company") plans to release its financial results for the fourth quarter of 2025 after the close of the New York Stock Exchange on Wednesday, February 18, 2026. A conference call and webcast are scheduled for 09:00 New York time (15:00 CET) on Thursday, February 19, 2026. The earnings report, webcast and accompanying presentation will be available on the Investor Relations section of the Company's website, www.borrdrilling.com. In order to listen to the live presentation, participants may do one of the following: a)    Webcast To access the webcast, please go to the following l

    1/30/26 10:09:00 AM ET
    $BORR
    Oil & Gas Production
    Energy

    GDS Announces Private Placement of US$300 Million convertible preferred shares to A Chinese Institutional Investor

    SHANGHAI, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ:GDS, HKEX: 9698)), a leading developer and operator of high-performance data centers in China, today announced a private placement of US$300 million of Series B convertible preferred shares (the "convertible preferred shares") to Huatai Capital Investment Limited, a Chinese institutional investor (the "Private Placement"). GDS will use the proceeds from the private placement to fund expansion of its data center capacity and for general corporate purposes. The convertible preferred shares include the following key terms: During the first six years from their issuance da

    1/30/26 8:40:00 AM ET
    $GDS
    Computer Software: Programming Data Processing
    Technology

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ALLR
    $ATHX
    $BJ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Citi Trends Inc.

    SC 13G/A - Citi Trends Inc (0001318484) (Subject)

    12/6/24 4:29:10 PM ET
    $CTRN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary